(CCS) Century Communities - Ratings and Ratios
Single-Family Homes, Land Development, Mortgage Services, Title Services, Insurance Services
Dividends
| Dividend Yield | 1.86% |
| Yield on Cost 5y | 2.75% |
| Yield CAGR 5y | 32.21% |
| Payout Consistency | 100.0% |
| Payout Ratio | 15.5% |
| Risk via 10d forecast | |
|---|---|
| Volatility | 39.5% |
| Value at Risk 5%th | 61.1% |
| Relative Tail Risk | -5.91% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.75 |
| Alpha | -41.29 |
| CAGR/Max DD | 0.17 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.377 |
| Beta | 0.692 |
| Beta Downside | 0.450 |
| Drawdowns 3y | |
|---|---|
| Max DD | 51.61% |
| Mean DD | 18.17% |
| Median DD | 12.21% |
Description: CCS Century Communities November 12, 2025
Century Communities, Inc. (NYSE:CCS) designs, develops, builds, markets, and sells single-family attached and detached homes across 18 U.S. states, offering its products under the “Century Communities” and “Century Complete” brands. The firm also handles land entitlement, construction, and provides ancillary services such as mortgage, title, and insurance to buyers, distributing homes through its own sales force, retail studios, online channels, and independent brokers. Founded in 2002, the company is headquartered in Greenwood Village, Colorado.
Key operational metrics from recent filings show FY 2023 revenue of roughly $2.5 billion and an average selling price (ASP) of about $350 k, reflecting a modest 3-4 % increase year-over-year despite a tightening housing market. The homebuilding sector remains highly sensitive to mortgage-rate fluctuations; the current 30-year Treasury yield near 4.8 % has pressured demand, while a resilient labor market and limited housing inventory continue to support pricing power. Additionally, CCS’s pipeline of land acquisitions in high-growth metros (e.g., Dallas-Fort Worth, Phoenix) positions it to capture upside if consumer confidence rebounds.
For a deeper, data-driven assessment of CCS’s valuation and risk profile, you may find ValueRay’s analytical tools useful for independent research.
Piotroski VR‑10 (Strict, 0-10) 4.0
| Net Income (214.4m TTM) > 0 and > 6% of Revenue (6% = 249.5m TTM) |
| FCFTA 0.04 (>2.0%) and ΔFCFTA 9.98pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 82.38% (prev 76.39%; Δ 5.99pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.06 (>3.0%) and CFO 262.6m > Net Income 214.4m (YES >=105%, WARN >=100%) |
| Net Debt (1.53b) to EBITDA (312.0m) ratio: 4.91 <= 3.0 (WARN <= 3.5) |
| Current Ratio 6.07 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (30.0m) change vs 12m ago -6.26% (target <= -2.0% for YES) |
| Gross Margin 19.99% (prev 21.97%; Δ -1.98pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 87.76% (prev 90.58%; Δ -2.82pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 78.22 (EBITDA TTM 312.0m / Interest Expense TTM 3.66m) >= 6 (WARN >= 3) |
Altman Z'' 7.79
| (A) 0.73 = (Total Current Assets 4.10b - Total Current Liabilities 675.1m) / Total Assets 4.69b |
| (B) 0.46 = Retained Earnings (Balance) 2.18b / Total Assets 4.69b |
| (C) 0.06 = EBIT TTM 286.3m / Avg Total Assets 4.74b |
| (D) 1.03 = Book Value of Equity 2.18b / Total Liabilities 2.12b |
| Total Rating: 7.79 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 51.40
| 1. Piotroski 4.0pt |
| 2. FCF Yield 5.93% |
| 3. FCF Margin 4.91% |
| 4. Debt/Equity 0.65 |
| 5. Debt/Ebitda 4.91 |
| 6. ROIC - WACC (= 0.49)% |
| 7. RoE 8.29% |
| 8. Rev. Trend -14.47% |
| 9. EPS Trend -36.11% |
What is the price of CCS shares?
Over the past week, the price has changed by -4.26%, over one month by +5.31%, over three months by -8.09% and over the past year by -27.76%.
Is CCS a buy, sell or hold?
- Strong Buy: 1
- Buy: 0
- Hold: 3
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the CCS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 66 | 5.6% |
| Analysts Target Price | 66 | 5.6% |
| ValueRay Target Price | 60.3 | -3.5% |
CCS Fundamental Data Overview December 03, 2025
P/E Trailing = 9.3746
P/E Forward = 12.3609
P/S = 0.4591
P/B = 0.7442
P/EG = 0.45
Beta = 1.535
Revenue TTM = 4.16b USD
EBIT TTM = 286.3m USD
EBITDA TTM = 312.0m USD
Long Term Debt = 1.32b USD (from longTermDebt, last quarter)
Short Term Debt = 339.0m USD (from shortTermDebt, last quarter)
Debt = 1.66b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.53b USD (from netDebt column, last quarter)
Enterprise Value = 3.44b USD (1.91b + Debt 1.66b - CCE 130.1m)
Interest Coverage Ratio = 78.22 (Ebit TTM 286.3m / Interest Expense TTM 3.66m)
FCF Yield = 5.93% (FCF TTM 204.2m / Enterprise Value 3.44b)
FCF Margin = 4.91% (FCF TTM 204.2m / Revenue TTM 4.16b)
Net Margin = 5.16% (Net Income TTM 214.4m / Revenue TTM 4.16b)
Gross Margin = 19.99% ((Revenue TTM 4.16b - Cost of Revenue TTM 3.33b) / Revenue TTM)
Gross Margin QoQ = 20.37% (prev 17.85%)
Tobins Q-Ratio = 0.73 (Enterprise Value 3.44b / Total Assets 4.69b)
Interest Expense / Debt = 0.87% (Interest Expense 14.5m / Debt 1.66b)
Taxrate = 21.81% (10.4m / 47.8m)
NOPAT = 223.8m (EBIT 286.3m * (1 - 21.81%))
Current Ratio = 6.07 (Total Current Assets 4.10b / Total Current Liabilities 675.1m)
Debt / Equity = 0.65 (Debt 1.66b / totalStockholderEquity, last quarter 2.58b)
Debt / EBITDA = 4.91 (Net Debt 1.53b / EBITDA 312.0m)
Debt / FCF = 7.51 (Net Debt 1.53b / FCF TTM 204.2m)
Total Stockholder Equity = 2.59b (last 4 quarters mean from totalStockholderEquity)
RoA = 4.57% (Net Income 214.4m / Total Assets 4.69b)
RoE = 8.29% (Net Income TTM 214.4m / Total Stockholder Equity 2.59b)
RoCE = 7.32% (EBIT 286.3m / Capital Employed (Equity 2.59b + L.T.Debt 1.32b))
RoIC = 5.39% (NOPAT 223.8m / Invested Capital 4.16b)
WACC = 4.90% (E(1.91b)/V(3.57b) * Re(8.57%) + D(1.66b)/V(3.57b) * Rd(0.87%) * (1-Tc(0.22)))
Discount Rate = 8.57% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -3.50%
[DCF Debug] Terminal Value 68.11% ; FCFE base≈204.2m ; Y1≈134.1m ; Y5≈61.3m
Fair Price DCF = 37.56 (DCF Value 1.10b / Shares Outstanding 29.4m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: -36.11 | EPS CAGR: -30.07% | SUE: 1.08 | # QB: 1
Revenue Correlation: -14.47 | Revenue CAGR: -5.39% | SUE: 0.67 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.34 | Chg30d=+0.120 | Revisions Net=+1 | Analysts=1
EPS next Year (2026-12-31): EPS=6.41 | Chg30d=-0.950 | Revisions Net=+0 | Growth EPS=+20.1% | Growth Revenue=+7.2%
Additional Sources for CCS Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle